EP 2061493 A1 20090527 - COMPOSITIONS TO REDUCE OR PREVENT SKIN CANCER
Title (en)
COMPOSITIONS TO REDUCE OR PREVENT SKIN CANCER
Title (de)
ZUSAMMENSETZUNGEN ZUR REDUZIERUNG ODER PRÄVENTION VON HAUTKREBS
Title (fr)
COMPOSITIONS POUR RÉDUIRE OU PRÉVENIR LE CANCER DE LA PEAU
Publication
Application
Priority
US 2006032549 W 20060821
Abstract (en)
[origin: WO2008024103A1] Compositions of human proteins, methods and regimens for reducing the occurrence and growth of skin cancer, including melanoma, are provided. The methods include steps of administering topically on the skin tumor or a skin cancer- free area of compositions containing therapeutically effective amounts of human alkaline phosphatase, transferrin and al -antitrypsin. In some embodiments, the composition is topically administered and includes all three proteins. Alkaline phosphatase, alone or in combination with transferrin and al -antitrypsin can also be administered by injection with or without simultaneous or sequential topical administration. Administration of compositions topically and/or by injection can be part of a more complex cancer therapy including chemotherapy, radiotherapy, surgery, and electrochemotherapy.
IPC 8 full level
A61K 38/16 (2006.01); A61K 38/46 (2006.01); A61K 38/57 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP)
A61K 31/382 (2013.01); A61K 31/40 (2013.01); A61K 33/30 (2013.01); A61K 38/40 (2013.01); A61K 38/465 (2013.01); A61K 38/57 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2017.12); C12Y 301/03001 (2013.01)
C-Set (source: EP)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR MK RS
DOCDB simple family (publication)
WO 2008024103 A1 20080228; EP 2061493 A1 20090527; EP 2061493 A4 20110112
DOCDB simple family (application)
US 2006032549 W 20060821; EP 06789889 A 20060821